Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan List

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|December 31, 2004
Methyltransferase inhibitors: changing the treatment algorithm for myelodysplastic syndromesAlan List
American Journal of Hematology|February 10, 2010
Deciphering the path ahead in myelodysplastic syndromeAlan List
Clinical Lymphoma & Myeloma|September 26, 2009
Lenalidomide--a transforming therapeutic agent in myelodysplastic syndromesAlan List
Best Practice & Research. Clinical Haematology|October 21, 2004
Histone deacetylase inhibitors in myelodysplastic syndromeKapil Bhalla, Alan List
Cancer Investigation|November 25, 2005
Immunomodulatory drugsEdward Crane, Alan List
Current Opinion in Oncology|October 2, 2007
Immunomodulatory drugs in the treatment of myelodysplastic syndromesJose Ortega, Alan List
Seminars in Hematology|July 15, 2005
Alternative treatments for myelodysplastic syndromesMikkael Sekeres, Alan List
The International Journal of Biochemistry & Cell Biology|March 21, 2007
The thalidomide sagaMagda Melchert, Alan List
Future Oncology (London, England)|March 25, 2006
Lenalidomide: an immunomodulatory drugEdward Crane, Alan List
Seminars in Hematology|January 9, 2008
Targeted therapies in myelodysplastic syndromeMagda Melchert, Alan List
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancer Control : Journal of the Moffitt Cancer Center|December 31, 2004
Methyltransferase inhibitors: changing the treatment algorithm for myelodysplastic syndromesAlan List
American Journal of Hematology|February 10, 2010
Deciphering the path ahead in myelodysplastic syndromeAlan List
Clinical Lymphoma & Myeloma|September 26, 2009
Lenalidomide--a transforming therapeutic agent in myelodysplastic syndromesAlan List
Best Practice & Research. Clinical Haematology|October 21, 2004
Histone deacetylase inhibitors in myelodysplastic syndromeKapil Bhalla, Alan List
Cancer Investigation|November 25, 2005
Immunomodulatory drugsEdward Crane, Alan List
Current Opinion in Oncology|October 2, 2007
Immunomodulatory drugs in the treatment of myelodysplastic syndromesJose Ortega, Alan List
Seminars in Hematology|July 15, 2005
Alternative treatments for myelodysplastic syndromesMikkael Sekeres, Alan List
The International Journal of Biochemistry & Cell Biology|March 21, 2007
The thalidomide sagaMagda Melchert, Alan List
Future Oncology (London, England)|March 25, 2006
Lenalidomide: an immunomodulatory drugEdward Crane, Alan List
Seminars in Hematology|January 9, 2008
Targeted therapies in myelodysplastic syndromeMagda Melchert, Alan List
Pageof 8